Torrent Pharmaceuticals Ltd. — Capital/Financing Update 2022

May 12, 2022

11[th ] May, 2020

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1[st ] Floor, New Trading Ring, P. J, Towers, Dalal Street, Fort� Mumbai - 400 001 (BSE Scrip Code: 500420)

==> picture [59 x 75] intentionally omitted <==

==> picture [126 x 41] intentionally omitted <==

The Manager- Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5 th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 051 (NSE Scrip Code: TORNTPHARM)

==> picture [7 x 22] intentionally omitted <==

Dear Sir,

Sub.: Initial Disclosure and Details of Incremental borrowings to be made by an entity identified as a Large Corporate pursuant to SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated 26-Nov-18

In accordance with the captioned subject, Torrent Pharmaceuticals Limited being a Large Corporate as per the criteria mentioned in the said circular, we enclose herewith the initial disclosure in the prescribed format (Annexure A) and the details of the incremental borrowings done during the FY in the prescribed format (Annexure Bl).

Kindly take note on above.

Thanking you,

==> picture [152 x 136] intentionally omitted <==

Yours sincerely,

For TORRENT PHARMACEUTICALS LI

==> picture [110 x 30] intentionally omitted <==

MAHESH AGRAWAL VP (LEGAL) & COMPANY SECRETARY Contact No: +91 79 26599000

Encl: A/a

==> picture [74 x 22] intentionally omitted <==

==> picture [575 x 91] intentionally omitted <==